Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Serine Synthesis via PHGDH Is Essential for Heme Production in Endothelial Cells.

Vandekeere S, Dubois C, Kalucka J, Sullivan MR, García-Caballero M, Goveia J, Chen R, Diehl FF, Bar-Lev L, Souffreau J, Pircher A, Kumar S, Vinckier S, Hirabayashi Y, Furuya S, Schoonjans L, Eelen G, Ghesquière B, Keshet E, Li X, Vander Heiden MG, Dewerchin M, Carmeliet P.

Cell Metab. 2018 Jul 6. pii: S1550-4131(18)30391-7. doi: 10.1016/j.cmet.2018.06.009. [Epub ahead of print]

PMID:
30017355
2.

Consensus guidelines for the use and interpretation of angiogenesis assays.

Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW.

Angiogenesis. 2018 May 15. doi: 10.1007/s10456-018-9613-x. [Epub ahead of print] Review.

3.

How Endothelial Cells Adapt Their Metabolism to Form Vessels in Tumors.

Zecchin A, Kalucka J, Dubois C, Carmeliet P.

Front Immunol. 2017 Dec 11;8:1750. doi: 10.3389/fimmu.2017.01750. eCollection 2017. Review.

4.

Tumor vessel disintegration by maximum tolerable PFKFB3 blockade.

Conradi LC, Brajic A, Cantelmo AR, Bouché A, Kalucka J, Pircher A, Brüning U, Teuwen LA, Vinckier S, Ghesquière B, Dewerchin M, Carmeliet P.

Angiogenesis. 2017 Nov;20(4):599-613. doi: 10.1007/s10456-017-9573-6. Epub 2017 Sep 5.

PMID:
28875379
5.

Role of glutamine and interlinked asparagine metabolism in vessel formation.

Huang H, Vandekeere S, Kalucka J, Bierhansl L, Zecchin A, Brüning U, Visnagri A, Yuldasheva N, Goveia J, Cruys B, Brepoels K, Wyns S, Rayport S, Ghesquière B, Vinckier S, Schoonjans L, Cubbon R, Dewerchin M, Eelen G, Carmeliet P.

EMBO J. 2017 Aug 15;36(16):2334-2352. doi: 10.15252/embj.201695518. Epub 2017 Jun 28.

6.

How to Cross the Lymphatic Fence: Lessons From Solute Transport.

Kalucka J, Teuwen LA, Geldhof V, Carmeliet P.

Circ Res. 2017 Apr 28;120(9):1376-1378. doi: 10.1161/CIRCRESAHA.117.310916. No abstract available.

PMID:
28450356
7.

Interaction of endothelial cells with macrophages-linking molecular and metabolic signaling.

Kalucka J, Bierhansl L, Wielockx B, Carmeliet P, Eelen G.

Pflugers Arch. 2017 Apr;469(3-4):473-483. doi: 10.1007/s00424-017-1946-6. Epub 2017 Feb 24. Review.

PMID:
28236120
8.

Vessel pruning or healing: endothelial metabolism as a novel target?

Cantelmo AR, Pircher A, Kalucka J, Carmeliet P.

Expert Opin Ther Targets. 2017 Mar;21(3):239-247. doi: 10.1080/14728222.2017.1282465. Epub 2017 Jan 27. Review.

9.

The role of fatty acid β-oxidation in lymphangiogenesis.

Wong BW, Wang X, Zecchin A, Thienpont B, Cornelissen I, Kalucka J, García-Caballero M, Missiaen R, Huang H, Brüning U, Blacher S, Vinckier S, Goveia J, Knobloch M, Zhao H, Dierkes C, Shi C, Hägerling R, Moral-Dardé V, Wyns S, Lippens M, Jessberger S, Fendt SM, Luttun A, Noel A, Kiefer F, Ghesquière B, Moons L, Schoonjans L, Dewerchin M, Eelen G, Lambrechts D, Carmeliet P.

Nature. 2017 Feb 2;542(7639):49-54. doi: 10.1038/nature21028. Epub 2016 Dec 26.

PMID:
28024299
10.

Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.

Cantelmo AR, Conradi LC, Brajic A, Goveia J, Kalucka J, Pircher A, Chaturvedi P, Hol J, Thienpont B, Teuwen LA, Schoors S, Boeckx B, Vriens J, Kuchnio A, Veys K, Cruys B, Finotto L, Treps L, Stav-Noraas TE, Bifari F, Stapor P, Decimo I, Kampen K, De Bock K, Haraldsen G, Schoonjans L, Rabelink T, Eelen G, Ghesquière B, Rehman J, Lambrechts D, Malik AB, Dewerchin M, Carmeliet P.

Cancer Cell. 2016 Dec 12;30(6):968-985. doi: 10.1016/j.ccell.2016.10.006. Epub 2016 Nov 17.

11.

Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities.

Goveia J, Pircher A, Conradi LC, Kalucka J, Lagani V, Dewerchin M, Eelen G, DeBerardinis RJ, Wilson ID, Carmeliet P.

EMBO Mol Med. 2016 Oct 4;8(10):1134-1142. doi: 10.15252/emmm.201606798. Print 2016 Oct.

12.

Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen.

Siegert I, Schödel J, Nairz M, Schatz V, Dettmer K, Dick C, Kalucka J, Franke K, Ehrenschwender M, Schley G, Beneke A, Sutter J, Moll M, Hellerbrand C, Wielockx B, Katschinski DM, Lang R, Galy B, Hentze MW, Koivunen P, Oefner PJ, Bogdan C, Weiss G, Willam C, Jantsch J.

Cell Rep. 2015 Dec 15;13(10):2048-55. doi: 10.1016/j.celrep.2015.11.005. Epub 2015 Nov 25.

13.

Targeting fatty acid metabolism in cancer and endothelial cells.

Harjes U, Kalucka J, Carmeliet P.

Crit Rev Oncol Hematol. 2016 Jan;97:15-21. doi: 10.1016/j.critrevonc.2015.10.011. Epub 2015 Nov 1. Review.

PMID:
26558689
14.

Metabolic control of the cell cycle.

Kalucka J, Missiaen R, Georgiadou M, Schoors S, Lange C, De Bock K, Dewerchin M, Carmeliet P.

Cell Cycle. 2015;14(21):3379-88. doi: 10.1080/15384101.2015.1090068.

15.

Formalin evokes calcium transients from the endoplasmatic reticulum.

Fischer MJ, Soller KJ, Sauer SK, Kalucka J, Veglia G, Reeh PW.

PLoS One. 2015 Apr 15;10(4):e0123762. doi: 10.1371/journal.pone.0123762. eCollection 2015.

16.

Kidney injury is independent of endothelial HIF-1α.

Kalucka J, Schley G, Georgescu A, Klanke B, Rössler S, Baumgartl J, Velden J, Amann K, Willam C, Johnson RS, Eckardt KU, Weidemann A.

J Mol Med (Berl). 2015 Aug;93(8):891-904. doi: 10.1007/s00109-015-1264-4. Epub 2015 Mar 11.

PMID:
25754172
17.

Lack of vascular endothelial growth factor receptor-2/Flk1 signaling does not affect substantia nigra development.

Hermann A, Loewenbrück KF, Boldt Ä, Fiedler C, Maisel M, Kalucka J, Schwarz J, Breier G, Storch A.

Neurosci Lett. 2013 Oct 11;553:142-7. doi: 10.1016/j.neulet.2013.08.031. Epub 2013 Aug 29.

PMID:
23994060
18.

Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.

Mamlouk S, Kalucka J, Singh RP, Franke K, Muschter A, Langer A, Jakob C, Gassmann M, Baretton GB, Wielockx B.

Int J Cancer. 2014 Feb 15;134(4):849-58. doi: 10.1002/ijc.28409. Epub 2013 Aug 29.

19.

Loss of epithelial hypoxia-inducible factor prolyl hydroxylase 2 accelerates skin wound healing in mice.

Kalucka J, Ettinger A, Franke K, Mamlouk S, Singh RP, Farhat K, Muschter A, Olbrich S, Breier G, Katschinski DM, Huttner W, Weidemann A, Wielockx B.

Mol Cell Biol. 2013 Sep;33(17):3426-38. doi: 10.1128/MCB.00609-13. Epub 2013 Jun 24.

20.

HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress.

Singh RP, Franke K, Kalucka J, Mamlouk S, Muschter A, Gembarska A, Grinenko T, Willam C, Naumann R, Anastassiadis K, Stewart AF, Bornstein S, Chavakis T, Breier G, Waskow C, Wielockx B.

Blood. 2013 Jun 27;121(26):5158-66. doi: 10.1182/blood-2012-12-471185. Epub 2013 May 10.

21.

HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis.

Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A, Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz DM, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B.

Blood. 2013 Feb 21;121(8):1436-45. doi: 10.1182/blood-2012-08-449181. Epub 2012 Dec 20.

22.

Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ.

Klotzsche-von Ameln A, Muschter A, Mamlouk S, Kalucka J, Prade I, Franke K, Rezaei M, Poitz DM, Breier G, Wielockx B.

Cancer Res. 2011 May 1;71(9):3306-16. doi: 10.1158/0008-5472.CAN-10-3838. Epub 2011 Mar 24.

23.

Vegf regulates embryonic erythroid development through Gata1 modulation.

Drogat B, Kalucka J, Gutiérrez L, Hammad H, Goossens S, Farhang Ghahremani M, Bartunkova S, Haigh K, Deswarte K, Nyabi O, Naessens M, Ferrara N, Klingmüller U, Lambrecht BN, Nagy A, Philipsen S, Haigh JJ.

Blood. 2010 Sep 23;116(12):2141-51. doi: 10.1182/blood-2010-01-264143. Epub 2010 Jun 16.

Supplemental Content

Loading ...
Support Center